Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT07068074 · ClinicalTrials.gov registry record · Phase 3
A Randomized Phase III Study of Management of Treatment Naive Primary Melanoma in Elderly Patients
A Phase 3 study, sponsored by Eastern Cooperative Oncology Group.
- Not yet
- Registry status
- Phase 3
- Development phase
- 428
- Enrollment target
NCT07068074 is a Phase 3 study that has not yet begun recruiting, run by Eastern Cooperative Oncology Group. The registered enrollment target is 428 participants.
The verdict
NCT07068074, a Phase 3 study, has not yet begun recruiting, sponsored by Eastern Cooperative Oncology Group.
- NOT YET RECRUITING
- Registry status
- Phase 3
- Development phase
- 428 participants
- Enrollment target
Study Summary
Can we treat your melanoma just as effectively without doing a sentinel lymph node (SLN) biopsy in addition to your wide local excision (WLE) procedure? A wide local excision (WLE) is a surgical procedure performed to cut out an abnormal lesion and some surrounding normal tissue. This is sometimes followed by a sentinel lymph node (SLN) biopsy, in which lymph nodes that cancer cells could spread to are removed as well. We are doing this study because we want to find out if performing the WLE alone is just as effective as the usual approach for your melanoma, and if it leads to improvements in patients' overall well-being. The usual approach is defined as care most people get for the early stage of melanoma that you currently have.
Interventions
- PROCEDURE Wide local Excision
- PROCEDURE Sentinel Lymph Node and Wide Local Excision
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 428 participants |
| Start Date | 2025-12-12 |
| Est. Completion | 2031-01-01 |
| Phase | Phase 3 |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT07068074
The ClinicalTrials.gov registry entry for NCT07068074 describes a study currently listed as not yet recruiting, categorized as Phase 3. The registered enrollment target is 428 participants, a figure that helps gauge the scale of data the investigators plan to collect. The listed sponsor is Eastern Cooperative Oncology Group, which has 141 total studies on file at ClinicalTrials.gov.
The record links to 0 conditions, and to 2 interventions - of which Wide local Excision is the first listed.
NCT07068074 reports 0 study locations.
Frequently Asked Questions
What is clinical trial NCT07068074 about?
NCT07068074 is a clinical study titled "A Randomized Phase III Study of Management of Treatment Naive Primary Melanoma in Elderly Patients". Can we treat your melanoma just as effectively without doing a sentinel lymph node (SLN) biopsy in addition to your wide local excision (WLE) procedure? A wide local excision (WLE) is a surgical procedure performed to cut out an abnormal lesion and some surrounding normal tissue. This is sometimes f...
What is the current status of trial NCT07068074?
This trial is currently not yet recruiting. It is a Phase 3 study. The enrollment target is 428 participants. The study started on 2025-12-12. Estimated completion is 2031-01-01.
What interventions are being tested in trial NCT07068074?
The interventions under investigation include: Wide local Excision (PROCEDURE), Sentinel Lymph Node and Wide Local Excision (PROCEDURE).
Who is sponsoring clinical trial NCT07068074?
This trial is sponsored by Eastern Cooperative Oncology Group, which has 141 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
Explore more on PlainTrial
Read our methodology - how this data is sourced, computed, and verified.
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.